Cargando…
Therapeutic targeting of the inflammasome in myeloid malignancies
Even though genetic perturbations and mutations are important for the development of myeloid malignancies, the effects of an inflammatory microenvironment are a critical modulator of carcinogenesis. Activation of the innate immune system through various ligands and signaling pathways is an important...
Autores principales: | Chakraborty, Samarpana, Shapiro, Lauren C., de Oliveira, Sofia, Rivera-Pena, Bianca, Verma, Amit, Shastri, Aditi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440507/ https://www.ncbi.nlm.nih.gov/pubmed/34521810 http://dx.doi.org/10.1038/s41408-021-00547-8 |
Ejemplares similares
-
Inflammasome Activation in Myeloid Malignancies—Friend or Foe?
por: Andina, Nicola, et al.
Publicado: (2022) -
Inflammasomes as therapeutic targets in human diseases
por: Li, Yangxin, et al.
Publicado: (2021) -
Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets
por: Govindarajan, Vaidya, et al.
Publicado: (2020) -
Inflammasome: structure, biological functions, and therapeutic targets
por: Dai, Yali, et al.
Publicado: (2023) -
P697: DISTINCT SPLICING ALTERATIONS ASSOCIATED WITH CLINICAL RESPONSE TO LUSPATERCEPT IN PATIENTS WITH LOWER‑RISK MYELODYSPLASTIC SYNDROMES FROM THE MEDALIST STUDY
por: Aluri, Srinivas, et al.
Publicado: (2023)